Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Follow-up on primary prevention trials

A D Marais1

  • 1Department of Internal Medicine, University of Cape Town Medical School, Republic of South Africa. dmarias@uctgshl.uct.ac.za

Current Opinion in Lipidology
|December 30, 1998
PubMed
Summary

Primary prevention trials show cardiovascular benefits without increased mortality. Selective, cost-effective LDL cholesterol reduction is key for high-risk patients, suggesting targeted interventions for coronary artery disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LDL-cholesterol targets and lipid-lowering therapies - a plea to medical schemes and the Council for Medical Schemes.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
Same author

Response to: Prescribed Minimum Benefits complaints: A 5-year retrospective review.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2024
Same author

Management of hyperlipidaemia.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2024
Same author

Premature cardiovascular deaths.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2023
Same author

[An abnormal lipid profile: when to perform additional research for a genetic cause?]

Nederlands tijdschrift voor geneeskunde·2023
Same author

Hypertriglyceridaemia in adolescents may have serious complications.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2022

Area of Science:

  • Cardiovascular disease prevention
  • Lipid management

Background:

  • Primary prevention trials demonstrate cardiovascular benefits of lipid-lowering therapies.
  • These benefits are observed without adverse effects on overall mortality or morbidity in broad patient cohorts.

Purpose of the Study:

  • To analyze the effectiveness of LDL cholesterol reduction in primary prevention of coronary artery disease.
  • To evaluate the cost-effectiveness of targeted lipid-modifying drug management in high-risk individuals.

Main Methods:

  • Analysis of data from primary prevention trials, including the West of Scotland Coronary Prevention Study and the Air Force/Texas Coronary Artery Prevention Study.
  • Evaluation of LDL cholesterol reduction thresholds and cost-effectiveness of interventions.

Main Results:

  • A 25% reduction in LDL cholesterol is associated with cardiovascular benefits.
  • Effective treatment is achievable and cost-effective in selected high-risk individuals.
  • Benefits are observed even at lower plasma lipid concentrations.

Conclusions:

  • Current lifestyle and drug management are successful in primary prevention.
  • Selective, cost-effective treatment is recommended for very high-risk individuals.
  • Future research should focus on specific at-risk cohorts, targeted therapies, and additional risk factors.

Related Experiment Videos